We questioned whether the ratio of C-reactive protein to high-molecular-weight adiponectin (C/A ratio), compared to each value alone, is more useful to predict insulin resistance and/or metabolic syndrome. Methods: We measured serum CRP and HMW adiponectin levels in 841 Japanese men who had participated in an annual health checkup. Correlations of the C/A ratio with metabolic parameters were assessed, and its predictive values for insulin resistance and MetS were compared with CRP or HMW adiponectin alone. Results: The C/A ratio was higher in subjects with MetS (n 114) than in those without MetS (0.46 0.67 vs. 0.23 0.39, p 0.0001). The C/A ratio was correlated with a larger number of metabolic parameters than CRP, but the correlation was comparable to HMW adiponectin. Likewise, the area under the curve of the C/A ratio in receiver operator characteristic analysis for MetS was greater than that of CRP, but comparable to that of HMW adiponectin. However, the AUC of the C/A ratio in ROC analysis for insulin resistance (HOMA-IR 2.5) was greater than that of CRP or HMW adiponectin alone. Conclusion: While the C/A ratio provided little advantage to predict MetS, it might be more useful to predict insulin resistance than CRP or HMW adiponectin alone. J Atheroscler Thromb, 2010; 17:944-952.
recognized as metabolic syndrome (MetS) 1) . Insulin resistance, visceral obesity and chronic inflammation have been proposed to be the central pathogenesis of MetS 1) ; therefore, various inflammatory markers have been reported to be indicators of MetS and CVD [2] [3] [4] . Among them, C-reactive protein (CRP) is one of the most widely used markers [2] [3] [4] . Increased CRP has been shown to be associated with obesity 5) and MetS 6) . Higher CRP levels have been shown to predict CVD [7] [8] [9] [10] . Since visceral obesity is also a hallmark of MetS, adiponectin, an adipokine secreted from adipose tissue, has also been reported to be a marker of MetS 11) . Lower adiponectin levels have been shown to be associated with visceral obesity 12) Introduction Cardiovascular disease (CVD) and cancer are leading causes of death in developed countries. Since over 300,000 people die from CVD in Japan every year, it is important to detect individuals at a high risk for CVD to encourage prevention. While obesity, hypertension, hyperglycemia and dyslipidemia are known risk factors of CVD, studies have revealed that a cluster of these metabolic abnormalities is itself an important risk factor of CVD, which has now been increased adiponectin prevents the development of atherosclerosis 17) . In particular, the high-molecularweight (HMW) form of adiponectin has been proposed to be an active form [18] [19] [20] . We and other groups have shown that HMW adiponectin levels are more strongly correlated with MetS and CVD than total adiponectin levels 13, 21, 22) . Basu et al. have also shown that HMW, but not low-molecular-weight, adiponectin is selectively decreased in individuals with type 2 diabetes, suggesting that HMW adiponectin plays an important role in the development of CVD 23) . Although CRP and HMW adiponectin are thought to be independent risk factors of CVD, an additive effect of both markers to evaluate MetS remains to be established. Establishing a robust biomarker that can predict MetS instead of examining individual features will be important to screen populations of individuals, monitor the natural history of the disease, and measure the response to therapeutic interventions. We and others have shown a synergistic effect of CRP and HMW adiponectin to evaluate MetS in the general population 24) and type 2 diabetic subjects 25) , suggesting a superior effect when both markers are combined. In contrast, Devaraj et al. have reported that CRP, HMW adiponectin and its ratio were comparable to predict MetS 26) . Therefore, in our large cohort of Japanese men, we examined whether the ratio of CRP to HMW adiponectin (C/A ratio) has any advantage to predict insulin resistance and/or MetS compared to each factor alone.
Methods

Subjects
This study included 841 Japanese male teachers and workers at Keio University aged 25 to 68 years (mean 48 10 years, Table 1 ) who underwent an annual health checkup in 2007. Information regarding smoking, alcohol intake, physical activity and medication was obtained from questionnaires. Subjects with endocrine disease, such as Cushing syndrome, significant renal or hepatic disease, or inflammatory disease (or CRP 10 mg/L) were excluded. Subjects receiving medication for dyslipidemia were also excluded. The present study was conducted according to the principles expressed in the Declaration of Helsinki. Informed consent was obtained from each subject after a full explanation of the purpose, nature and risk of all procedures used. The protocol was approved by the ethics review committees of the Health Center and the Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Measurement
Systolic and diastolic blood pressures were measured in the sitting position after resting for at least 3 min. Blood samples were collected the morning after an overnight fast.
Plasma glucose and serum lipids were assayed by routine automated laboratory methods as described previously 13, 25, 27, 28) . Serum insulin concentration was measured by an enzyme immunoassay, using a commercially available kit (Tosoh, Tokyo, Japan), with intra-and interassay coefficients of 2.9 to 4.6% and 4.5 to 7.0%, respectively. The insulin resistance index was assessed by a homeostasis model assessment of insulin resistance (HOMA-IR), which was calculated as fasting serum insulin (mU/L) fasting plasma glucose (mmol/L)/22.5.
HMW adiponectin was measured using a commercially available kit (HMW adiponectin ELISA Kit; Fujirebio, Tokyo, Japan) as previously reported 13, 25, 27, 28) . This ELISA system does not need a denaturing step, and the monoclonal antibody (IH7) is reported to react specifically with the HMW form of adiponectin 29) . The dilution curve was parallel to the standard curve. Intra-and interassay coefficients were 2.4 to 3.0% and 4.2 to 5.1%, respectively. Serum CRP levels were measured by nephelometry, a latex particleenhanced immunoassay (N Latex CRP ; Dade Behring, Tokyo, Japan) with both intra-and interassay coefficients of 5.0%.
Definition of Metabolic Syndrome (MetS)
MetS was defined according to the revised NCEP criteria 30) as 3 or more of 5 components in which the cut-off point of the waist circumference was modified for Japanese as ≥ 90 cm in men according to the recommendation by the International Diabetes Federation (IDF) 31) ; the cut-off points of the other components were systolic blood pressure ≥ 130 mmHg and/or diastolic blood pressure ≥ 85 mmHg for blood pressure, ≥ 150 mg/dL for triglycerides, 40 mg/dL for HDL-cholesterol, and ≥ 100 mg/dL for fasting plasma glucose. Subjects receiving antihypertensive or hypoglycemic medication were considered to have the respective component. Japanese metabolic syndrome (JMetS) defined by the Examination Committee for Criteria of Metabolic Syndrome 32) was also examined. The criteria of JMetS is waist circumference ≥ 85 cm (for men) plus 2 or more of the following 3 components; systolic blood pressure ≥ 130 mmHg and/or diastolic blood pressure ≥ 85 mmHg, triglycerides ≥ 150 mg/dL and/or HDL cholesterol 40 mg/dL, and fasting plasma glucose ≥ 110 mg/dL.
Statistical Analysis
Comparisons between two groups were performed with Student t -tests. Relationships between two parameters were determined by simple regression analysis. Stepwise regression analysis was performed in a forward direction with F for the entry set to 4. Odds ratios were determined between first and third tertiles by logistic regression analysis. These statistical analyses were performed using the StatView program for Windows (version 5.0; SAS Institute Inc., Cary, NC, USA). Receiver operator characteristic (ROC) curves for insulin resistance and MetS were plotted and the area under the curve (AUC) of ROC curves was analyzed using the Statistical Package for the Social Sciences (version 17.0; SPSS, Chicago, IL, USA). Because AST, ALT, -GTP, HDL-cholesterol, triglyceride, insulin, HOMA-IR, CRP, HMW adiponectin and C/A ratio were normally distributed after logarithmic transformation, the logarithms of these parameters were used for analyses. All data are expressed as the mean S.D., and values of p 0.05 were considered significant.
Results
CRP, HMW Adiponectin and its Ratio in Subjects with or without MetS
Characteristics of the subjects are shown in Table 1 . In all subjects, mean CRP and HMW adiponectin levels were 0.61 0.79 mg/L and 3.84 2.54 g/mL, 30, 31) . JMetS; metabolic syndrome by Japanese criteria 32) . p 0.05, p 0.01, p 0.001, p 0.0001 vs. MetS( ) or JMetS( ).
respectively. A weak but significant negative correlation existed between CRP and HMW adiponectin (r 0.16, p 0.0001, Fig. 1 ). Among them, 114 (13.6%) and 95 (11.3%) subjects were diagnosed with MetS and JMetS, respectively ( Table 1) . Subjects with MetS were more insulin resistant than those without MetS (HOMA-IR: 2.16 1.97 vs. 1.17 1.02, p 0.0001). CRP levels were significantly higher and HMW adiponectin levels were significantly lower in subjects with MetS than in those without MetS (CRP: 0.87 0.98 vs. 0.58 0.75 mg/L, p 0.001 and HMW adiponectin: 2.69 1.80 vs. 4.01 2.59 g/mL, p 0.0001, respectively). As a result, the CRP to HMW adiponectin ratio (C/A ratio) was significantly higher in subjects with MetS than in those without MetS (0.46 0.67 vs. 0.23 0.39, p 0.0001). Similarly, the C/A ratio was also significantly higher in subjects with JMetS than in those without JMetS (0.51 0.72 vs. 0.23 0.39, p 0.0001, Table 1 ).
Correlations of CRP, HMW Adiponectin and its Ratio with Metabolic Parameters
As expected, both CRP and HMW adiponectin were significantly associated with various metabolic parameters, while HMW adiponectin appeared to correlate with a larger number of metabolic parameters, including blood pressure, compared to CRP ( Table 2) . The C/A ratio was also significantly correlated with various metabolic parameters and was comparable to HMW adiponectin: i.e., the C/A ratio was significantly positively correlated with age (r 0. Table 2 ).
ROC Analysis for Insulin Resistance and MetS
Stepwise regression analysis revealed that CRP and HMW adiponectin were independently associated with HOMA-IR after adjustment for age ( 0 To confirm the synergistic effects of HMW adiponectin on CRP, the subjects were then divided into tertiles based on CRP and HMW adiponectin levels, respectively. CRP levels of each tertile were as follows: lowest tertile: 0.21 mg/L or less, median tertile: 0.22 to 0.54 mg/L, highest tertile: 0.55 mg/L or more. HMW adiponectin levels of each tertile were as follows: lowest tertile: 2.4 g/mL or less, median tertile: 2.5 to 4.2 g/mL, highest tertile: 4.3 g/mL or more. As a result, components of MetS and HOMA-IR were both highest in the highest CRP-lowest HMW adiponectin tertile group and lowest in the lowest CRPhighest HMW adiponectin tertile group (Fig. 2) , while HMW adiponectin appeared to be a more dominant determinant for components of MetS than CRP ( Fig. 2A) . CRP and HMW adiponectin were independently associated with the both numbers of MetS components and HOMA-IR (p 0.05 by two-way ANOVA). The odds ratio (first tertile vs. third tertile) for insulin resistance (HOMA-IR 2.5) was higher for the C/A ratio (8.05, 95% CI; 3.11 − 20.85) than CRP (4.43, 95% CI; 2.09 − 9.38) or HMW adiponectin (3.34, 95% CI; 1.66 − 6.73) ( Table 3) ; however, the odds ratio for MetS or JMetS in the C/A ratio (4.02 and 6.20, 95% CI; 2.31 − 7.01 and 3.17 − 12.11, respectively) was rather comparable to that in HMW adiponectin (3.70 and 5.39, 95% CI; 2.14 − 6.38 and 2.82 − 10.31, respectively) or CRP (2.18 and 2.36, 95% CI; 1.33 − 3.58 and 1.38 − 4.03, respectively) ( Table 3) .
Thus, to examine the superiority of the C/A ratio to CRP and HMW adiponectin alone, we performed a ROC analysis of CRP, HMW adiponectin and the C/A ratio to evaluate insulin resistance and MetS. The AUC of the C/A ratio for MetS (0.67, 95% CI; 0.62 − 0.72) was greater than that of CRP (0.61, 95% CI; 0.55 − 0.67), but comparable to that of HMW adiponectin (0.67, 95% CI; 0.62 − 0.72) (Fig. 3A) . Similar (Fig. 3B) . In contrast, although the 95% CI overlapped, the AUC of the C/A ratio for insulin resistance (0.71, 95% CI; 0.65 − 0.78) was greater than that of CRP (0.67, 95% CI; 0.60 − 0.74) or HMW adiponectin (0.67, 95% CI; 0.59 − 0.74) (Fig. 3C) . 
A B
Discussion
In this study we reported that CRP and HMW adiponectin, an active form of adiponectin, synergistically reflected metabolic abnormalities. The C/A ratio showed little advantage to predict MetS, while it better predicted insulin resistance than CRP or HMW adiponectin alone.
Both CRP [6] [7] [8] [9] [10] and adiponectin 11, 13, 16, 21, 22) have been shown to be predictors of MetS and CVD. A decrease in CRP levels has been shown to correlate with the prevention of CVD [7] [8] [9] [10] . Decreased adiponectin has also been reported to associate with the onset of CVD 16) . Moreover, an inverse correlation between CRP and adiponectin has been shown in blood and adipose tissue 33) , and direct suppression of CRP by adiponectin has been reported 34) , which suggests a direct correlation between CRP and adiponectin. Recently, Tabara et al. have shown synergistic effects of CRP and HMW adiponectin on metabolic abnormalities in older Japanese subjects 24) , which indicate the superiority of a combination of both markers. We have also reported the synergistic effects of both markers on metabolic abnormalities in Japanese type 2 diabetic subjects 25) ; however, these studies did not measure waist circumference to evaluate MetS. In contrast, Devaraj et al. have reported a comparison among CRP, HMW adiponectin and its ratio in the evaluation of MetS in 123 subjects with MetS and 91 subjects without MetS 26) . They have reported that the measurement of CRP is equivalent to the measurement of HMW adiponectin and its ratio to CRP in predicting MetS 26) . The present study utilized a larger sample size coupled with the measurement of waist circumference 
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to confirm that the C/A ratio is comparable to HMW adiponectin as a predictor of MetS. While both CRP and HMW adiponectin predict MetS, these results indicate that the additive effect of both markers for the prediction of MetS is minimal.
Nonetheless, our study showed that the C/A ratio reflects more insulin-resistant subjects than CRP or HMW adiponectin alone. In fact, recent studies have indicated different characteristics between CRP and MetS [35] [36] [37] . It has been reported that CRP predicted the development of CVD independently of MetS 38) ; therefore, the addition of CRP to the criteria of MetS has been proposed 39) . In the present study, stepwise regression analysis also revealed that CRP and HMW adiponectin are independently associated with insulin resistance and the number of MetS components. It has been reported that CRP is more closely correlated with obesity itself (i.e., total fat) rather than visceral fat 35, 37) , while HMW adiponectin is closely correlated with visceral fat 12) . Consistent with this, in the present study, the correlation between CRP and HMW adiponectin was significant, but weak. Moreover HMW adiponectin is more closely correlated with the number of MetS components or MetS itself than CRP, in line with the previous study 11) . Whereas insulin resistance, visceral obesity and chronic inflammation are all hallmarks of MetS, the precise mechanism of MetS remains to be elucidated 1) . It is possible that the combination of CRP and HMW adiponectin is more closely correlated with insulin resistance rather than MetS, as defined by the sum of each metabolic abnormality 30) . Indeed Meigs et al. have reported that metabolic syndrome without insulin resistance did not increase the risk for CVD 40) . Since insulin resistance itself is a strong predictor of the onset of CVD 41) , the C/A ratio may have an advantage to detect subjects at risk for CVD compared to CRP or HMW adiponectin alone, possibly even better than MetS.
There are several limitations in this study. First, the cross-sectional study design; while no advantage was found for the C/A ratio to predict MetS, the possibility cannot be excluded. Likewise, while there was some advantage of the C/A ratio to predict insulin resistance, it remains unknown whether the C/A ratio has any advantage to predict the future development of CVD. Second, we recruited only Japanese male participants. Serum CRP or HMW adiponectin levels as well as adiposity differ between Asians and Caucasians and between genders; our results therefore may not be reflected in women or in other ethnicities. Also, since we collected participants from the general population, the sample size of MetS was relatively small. Moreover, the frequency of JMetS in our cohort was lower than that in the National Health and Nutrition Survey of Ministry of Health, Labour and Welfare, Japan in 2007 reporting 22.5% among adult men. This may be because our cohort consisted of men working at academic institutions, which might influence the ROC analysis for MetS.
In conclusion, while the C/A ratio provided little advantage to predict MetS, it might be more useful to predict the presence of insulin resistance than CRP or HMW adiponectin alone. It will be of interest to test whether the C/A ratio better predicts the development of CVD than CRP or HMW adiponectin alone. Further prospective studies will be warranted to clarify this question.
